Thursday, August 17, 2017 12:32:09 PM
Stock Purchase 1,499,408 shares at a cost of $6,850,408 with an average of $4.57 a share
https://www.sec.gov/Archives/edgar/data/1415684/000117152015000424/eps6333.htm
Convertible Note 1: $6m @ 10% due 11/8/2017
https://www.sec.gov/Archives/edgar/data/1415684/000141568417000006/mslp0114178k.htm
Convertible Note 2: $11m @ 10% due 11/8/2017
https://www.sec.gov/Archives/edgar/data/1415684/000114420416134521/v453052_sc13da.htm
MCF Settlement Note $1m @15% open maturity
https://www.sec.gov/Archives/edgar/data/1415684/000165495417006753/mslp_8k.htm
The CEO salary is $550K per annum with an additional $1.3m cash bonus.
Another $1.85m in interest payments on the 3 notes due him per annum.
Current CEO is raking $3.7m in cash per annum in addition to stock grants
At that compensation, current CEO is making 15% per annum on his investment with secured collateral
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM